A5030358407- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Venous Thromboembolism Diagnosis and Management
- Extracellular vesicles in disease
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Pleural and Pulmonary Diseases
- Medical Imaging and Pathology Studies
- Inhalation and Respiratory Drug Delivery
Brigham and Women's Hospital
2021-2023
Harvard University
2023
Einstein Medical Center Philadelphia
2023
Screening for pulmonary fibrosis may help to identify early stages of the disease. We assessed psychological impact screening undiagnosed first-degree relatives patients with by administering two validated measures after participants received their results: Decisional Regret Scale and Feelings About genomiC Testing Results Questionnaire. More than 90% reported either no or mild decisional regret. Increased regret negative feelings were present in those found have a low diffusion capacity...
Abstract High‐resolution computed tomography (HRCT) imaging is critical for diagnostic evaluation of Idiopathic Pulmonary Fibrosis (IPF). However, several other interstitial lung diseases (ILDs) often exhibit radiologic pattern similar to IPF on HRCT making the diagnosis disease difficult. Therefore, biomarkers that distinguish from ILDs can be a valuable aid in diagnosis. Using mass spectrometry, we performed proteomic analysis plasma extracellular vesicles (EVs) patients diagnosed with...
Background Given the heterogeneity of predisposing factors associated with pulmonary infarction (PI) and lack clinically relevant outcomes among patients acute embolism (PE) complicated by PI, further investigation is required.